New Tool Overcomes Major Hurdle in Clinical AI Design

Harvard Medical School scientists and colleagues at Stanford University have developed an artificial intelligence (AI) diagnostic tool that can detect diseases on chest X-rays directly from natural-language descriptions contained in accompanying clinical reports.

The step is deemed a major advance in clinical AI design because most current AI models require laborious human annotation of vast reams of data before the labeled data are fed into the model to train it.

A report on the work, published Sept. 15 in Nature Biomedical Engineering, shows that the model, called CheXzero, performed on par with human radiologists in its ability to detect pathologies on chest X-rays.

The team has made the code for the model publicly available for other researchers.

Most AI models require labeled datasets during their "training" so they can learn to correctly identify pathologies. This process is especially burdensome for medical image-interpretation tasks since it involves large-scale annotation by human clinicians, which is often expensive and time-consuming. For instance, to label a chest X-ray dataset, expert radiologists would have to look at hundreds of thousands of X-ray images one by one and explicitly annotate each one with the conditions detected. While more recent AI models have tried to address this labeling bottlenck by learning from unlabeled data in a "pre-training" stage, they eventually require fine-tuning on labeled data to achieve high performance.

By contrast, the new model is self-supervised, in the sense that it learns more independently, without the need for hand-labeled data before or after training. The model relies solely on chest X-rays and the English-language notes found in accompanying X-ray reports.

"We’re living the early days of the next-generation medical AI models that are able to perform flexible tasks by directly learning from text," said study lead investigator Pranav Rajpurkar, assistant professor of biomedical informatics in the Blavatnik Institute at HMS. "Up until now, most AI models have relied on manual annotation of huge amounts of data - to the tune of 100,000 images - to achieve a high performance. Our method needs no such disease-specific annotations.

"With CheXzero, one can simply feed the model a chest X-ray and corresponding radiology report, and it will learn that the image and the text in the report should be considered as similar - in other words, it learns to match chest X-rays with their accompanying report," Rajpurkar added. "The model is able to eventually learn how concepts in the unstructured text correspond to visual patterns in the image."

The model was "trained" on a publicly available dataset containing more than 377,000 chest X-rays and more than 227,000 corresponding clinical notes. Its performance was then tested on two separate datasets of chest X-rays and corresponding notes collected from two different institutions, one of which was in a different country. This diversity of datasets was meant to ensure that the model performed equally well when exposed to clinical notes that may use different terminology to describe the same finding.

Upon testing, CheXzero successfully identified pathologies that were not explicitly annotated by human clinicians. It outperformed other self-supervised AI tools and performed with accuracy similar to that of human radiologists.

The approach, the researchers said, could eventually be applied to imaging modalities well beyond X-rays, including CT scans, MRIs, and echocardiograms.

"CheXzero shows that accuracy of complex medical image interpretation no longer needs to remain at the mercy of large labeled datasets," said study co-first author Ekin Tiu, an undergraduate student at Stanford and a visiting researcher at HMS. "We use chest X-rays as a driving example, but in reality CheXzero's capability is generalizable to a vast array of medical settings where unstructured data is the norm, and precisely embodies the promise of bypassing the large-scale labeling bottleneck that has plagued the field of medical machine learning."

Tiu E, Talius E, Patel P et al.
Expert-level detection of pathologies from unannotated chest X-ray images via self-supervised learning.
Nat. Biomed. Eng, 2022. doi: 10.1038/s41551-022-00936-9

Most Popular Now

Unlocking the 10 Year Health Plan

The government's plan for the NHS is a huge document. Jane Stephenson, chief executive of SPARK TSL, argues the key to unlocking its digital ambitions is to consider what it...

Alcidion Grows Top Talent in the UK, wit…

Alcidion has today announced the addition of three new appointments to their UK-based team, with one internal promotion and two external recruits. Dr Paul Deffley has been announced as the...

AI can Find Cancer Pathologists Miss

Men assessed as healthy after a pathologist analyses their tissue sample may still have an early form of prostate cancer. Using AI, researchers at Uppsala University have been able to...

AI, Full Automation could Expand Artific…

Automated insulin delivery (AID) systems such as the UVA Health-developed artificial pancreas could help more type 1 diabetes patients if the devices become fully automated, according to a new review...

How AI could Speed the Development of RN…

Using artificial intelligence (AI), MIT researchers have come up with a new way to design nanoparticles that can more efficiently deliver RNA vaccines and other types of RNA therapies. After training...

New Training Year Starts at Siemens Heal…

In September, 197 school graduates will start their vocational training or dual studies in Germany at Siemens Healthineers. 117 apprentices and 80 dual students will begin their careers at Siemens...

MIT Researchers Use Generative AI to Des…

With help from artificial intelligence, MIT researchers have designed novel antibiotics that can combat two hard-to-treat infections: drug-resistant Neisseria gonorrhoeae and multi-drug-resistant Staphylococcus aureus (MRSA). Using generative AI algorithms, the research...

AI Hybrid Strategy Improves Mammogram In…

A hybrid reading strategy for screening mammography, developed by Dutch researchers and deployed retrospectively to more than 40,000 exams, reduced radiologist workload by 38% without changing recall or cancer detection...

Penn Developed AI Tools and Datasets Hel…

Doctors treating kidney disease have long depended on trial-and-error to find the best therapies for individual patients. Now, new artificial intelligence (AI) tools developed by researchers in the Perelman School...

Are You Eligible for a Clinical Trial? C…

A new study in the academic journal Machine Learning: Health discovers that ChatGPT can accelerate patient screening for clinical trials, showing promise in reducing delays and improving trial success rates. Researchers...

Global Study Reveals How Patients View M…

How physicians feel about artificial intelligence (AI) in medicine has been studied many times. But what do patients think? A team led by researchers at the Technical University of Munich...

New AI Tool Addresses Accuracy and Fairn…

A team of researchers at the Icahn School of Medicine at Mount Sinai has developed a new method to identify and reduce biases in datasets used to train machine-learning algorithms...